AAAAAA

   
Results: 1-10 |
Results: 10
EmtA, a rRNA methyltransferase conferring high-level evernimicin resistance
Authors: Mann, PA Xiong, LQ Mankin, AS Chau, AS Mendrick, CA Najarian, DJ Cramer, CA Loebenberg, D Coates, E Murgolo, NJ Aarestrup, FM Goering, RV Black, TA Hare, RS McNicholas, PM
Citation: Pa. Mann et al., EmtA, a rRNA methyltransferase conferring high-level evernimicin resistance, MOL MICROB, 41(6), 2001, pp. 1349-1356
In vitro Gram-positive antimicrobial activity of evernimicin (SCH 27899), a novel oligosaccharide, compared with other antimicrobials: a multicentre international trial
Authors: Jones, RN Hare, RS Sabatelli, FJ
Citation: Rn. Jones et al., In vitro Gram-positive antimicrobial activity of evernimicin (SCH 27899), a novel oligosaccharide, compared with other antimicrobials: a multicentre international trial, J ANTIMICRO, 47(1), 2001, pp. 15-25
Effects of mutations in ribosomal protein L16 on susceptibility and accumulation of evernimicin
Authors: McNicholas, PM Mann, PA Najarian, DJ Miesel, L Hare, RS Black, TA
Citation: Pm. Mcnicholas et al., Effects of mutations in ribosomal protein L16 on susceptibility and accumulation of evernimicin, ANTIM AG CH, 45(1), 2001, pp. 79-83
Genetic footprinting in bacteria
Authors: Hare, RS Walker, SS Dorman, TE Greene, JR Guzman, LM Kenney, TJ Sulavik, MC Baradaran, K Houseweart, C Yu, HY Foldes, Z Motzer, A Walbridge, M Shimer, GH Shaw, KJ
Citation: Rs. Hare et al., Genetic footprinting in bacteria, J BACT, 183(5), 2001, pp. 1694-1706
In vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and Candida
Authors: Cacciapuoti, A Loebenberg, D Corcoran, E Menzel, F Moss, EL Norris, C Michalski, M Raynor, K Halpern, J Mendrick, C Arnold, B Antonacci, B Parmegiani, R Yarosh-Tomaine, T Miller, GH Hare, RS
Citation: A. Cacciapuoti et al., In vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and Candida, ANTIM AG CH, 44(8), 2000, pp. 2017-2022
Evernimicin binds exclusively to the 50S ribosomal subunit and inhibits translation in cell-free systems derived from both gram-positive and gram-negative bacteria
Authors: McNicholas, PM Najarian, DJ Mann, PA Hesk, D Hare, RS Shaw, KJ Black, TA
Citation: Pm. Mcnicholas et al., Evernimicin binds exclusively to the 50S ribosomal subunit and inhibits translation in cell-free systems derived from both gram-positive and gram-negative bacteria, ANTIM AG CH, 44(5), 2000, pp. 1121-1126
Efficacy of SCH27899 in an animal model of Legionnaires' disease using immunocompromised A/J mice
Authors: Brieland, JK Loebenberg, D Menzel, F Hare, RS
Citation: Jk. Brieland et al., Efficacy of SCH27899 in an animal model of Legionnaires' disease using immunocompromised A/J mice, ANTIM AG CH, 44(5), 2000, pp. 1333-1336
Mutations in ribosomal protein L16 conferring reduced susceptibility to evernimicin (SCH27899): Implications for mechanism of action
Authors: Adrian, PV Zhao, WJ Black, TA Shaw, KJ Hare, RS Klugman, KP
Citation: Pv. Adrian et al., Mutations in ribosomal protein L16 conferring reduced susceptibility to evernimicin (SCH27899): Implications for mechanism of action, ANTIM AG CH, 44(3), 2000, pp. 732-738
Evernimicin (SCH27899) inhibits a novel ribosome target site: Analysis of 23S ribosomal DNA mutants
Authors: Adrian, PV Mendrick, C Loebenberg, D McNicholas, P Shaw, KJ Klugman, KP Hare, RS Black, TA
Citation: Pv. Adrian et al., Evernimicin (SCH27899) inhibits a novel ribosome target site: Analysis of 23S ribosomal DNA mutants, ANTIM AG CH, 44(11), 2000, pp. 3101-3106
Genomics and antimicrobial drug discovery
Authors: Moir, DT Shaw, KJ Hare, RS Vovis, GF
Citation: Dt. Moir et al., Genomics and antimicrobial drug discovery, ANTIM AG CH, 43(3), 1999, pp. 439-446
Risultati: 1-10 |